Somatostatin (BCN Peptides)

生长抑素（BCN Peptides）

Report date: 2022/11/25 18:11:10

Base Information

Drug NameSomatostatin (BCN Peptides)
Drug Alias NameSomatostatin 0.1% eye drops生长抑素0.1%滴眼液COLIRIOBCN070660
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionCorticotropin-releasing hormone inhibitorsGrowth hormone releasing factor antagonists
TargetsCorticotropin-releasing factor receptor 1Growth hormone releasing factor
Therapy Area/IndicationsDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPortugalItalyDenmark +[7] 
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBcn Peptides Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBcn Peptides Sa
Active IndicationsN/A
Inactive IndicationsDiabetic Retinopathy

Other Information

ATC CodeH01CB01
Related LinksWikipediaDrugBankKEGG